We recently reported that abundant deposits of the extracellular matrix polysaccharide hyaluronan (HA) are characteristic of autoimmune insulitis in patients with type 1 diabetes (T1D), but the relevance of these deposits to disease was unclear. Here, we have demonstrated that HA is critical for the pathogenesis of autoimmune diabetes. Using the DO11.10xRIPmOVA mouse model of T1D, we determined that HA deposits are temporally and anatomically associated with the development of insulitis. Moreover, treatment with an inhibitor of HA synthesis, 4-methylumbelliferone (4-MU), halted progression to diabetes even after the onset of insulitis. Similar effects were seen in the NOD mouse model, and in these mice, 1 week of treatment was sufficient to prevent subsequent diabetes. 4-MU reduced HA accumulation, constrained effector T cells to nondestructive insulitis, and increased numbers of intraislet FOXP3+ Tregs. Consistent with the observed effects of 4-MU treatment, Treg differentiation was inhibited by HA and anti-CD44 antibodies and rescued by 4-MU in an ERK1/2-dependent manner. These data may explain how peripheral immune tolerance is impaired in tissues under autoimmune attack, including islets in T1D. We propose that 4-MU, already an approved drug used to treat biliary spasm, could be repurposed to prevent, and possibly treat, T1D in at-risk individuals.
Nadine Nagy, Gernot Kaber, Pamela Y. Johnson, John A. Gebe, Anton Preisinger, Ben A. Falk, Vivekananda G. Sunkari, Michel D. Gooden, Robert B. Vernon, Marika Bogdani, Hedwich F. Kuipers, Anthony J. Day, Daniel J. Campbell, Thomas N. Wight, Paul L. Bollyky
Title and authors | Publication | Year |
---|---|---|
High Molecular Weight Hyaluronan Attenuates Tubulointerstitial Scarring in Kidney Injury
Xinyi Wang, Swathi Balaji, Emily H. Steen, Alexander J. Blum, Hui Li, Christina K. Chan, Scott R. Manson, Thomas C. Lu, Meredith M. Rae, Paul F. Austin, Thomas N. Wight, Paul L. Bollyky, Jizhong Cheng, Sundeep G. Keswani |
JCI Insight | 2020 |
Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts
E Galgoczi, F Jeney, M Katko, A Erdei, A Gazdag, L Sira, M Bodor, E Berta, B Ujhelyi, Z Steiber, F Gyory, EV Nagy |
Investigative ophthalmology & visual science | 2020 |
The Heparan Sulfate Mimetic PG545 Modulates T Cell Responses and Prevents Delayed-Type Hypersensitivity
IO Koliesnik, HF Kuipers, CO Medina, S Zihsler, D Liu, JD Belleghem, PL Bollyky |
Frontiers in immunology | 2020 |
The liver fibrosis niche: Novel insights into the interplay between fibrosis-composing mesenchymal cells, immune cells, endothelial cells, and extracellular matrix
M Matsuda, E Seki |
Food and Chemical Toxicology | 2020 |
Weekly injection of IL-2 using an injectable hydrogel reduces autoimmune diabetes incidence in NOD mice
N Nagy, G Kaber, MJ Kratochvil, HF Kuipers, SM Ruppert, K Yadava, J Yang, SC Heilshorn, SA Long, A Pugliese, PL Bollyky |
Diabetologia | 2020 |
The Inter-α-Trypsin Inhibitor Family: Versatile Molecules in Biology and Pathology
M S., J Melrose, AJ Day, JM Whitelock |
Journal of Histochemistry & Cytochemistry | 2020 |
Synucleinopathy alters nanoscale organization and diffusion in the brain extracellular space through hyaluronan remodeling
FN Soria, C Paviolo, E Doudnikoff, ML Arotcarena, A Lee, N Danné, AK Mandal, P Gosset, B Dehay, L Groc, L Cognet, E Bezard |
Nature Communications | 2020 |